JUP and Alzheimer disease: Although these studies targeted diseases other than AD (e.g., Streptococcus equi in equine strangles or Mycobacterium bovis in BCG vaccines), the underlying principles of mucosal immunisation and polymeric carrier systems are highly relevant to developing a nanovaccine for Pg as a prophylactic strategy against AD.